Press release
Geographic Atrophy Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Apellis Pharmaceuticals, Iveric bio., Belite Bio, NGM Biopharmaceuticals, Novartis, CellCure Neurosciences
The Geographic Atrophy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Geographic Atrophy pipeline products will significantly revolutionize the Geographic Atrophy market dynamics.DelveInsight's "Geographic Atrophy Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Geographic Atrophy, historical and forecasted epidemiology as well as the Geographic Atrophy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Geographic Atrophy market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Geographic Atrophy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Geographic Atrophy Market Insights
https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Geographic Atrophy Market Report:
• The Geographic Atrophy market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In the year 2021, the total prevalent case of Geographic Atrophy was 3,056,205 cases in the 7MM. These cases are expected to grow with a significant CAGR in the study period 2019-2032
• In the 7MM, the total diagnosed cases of Geographic Atrophy were 2,822,853 cases in 2021. These cases are expected to grow with a significant CAGR in the study period 2019-2032
• Globally, more than 5 million people are affected by Geographic Atrophy. Also, as per the published study by GER group, the global prevalence of Geographic Atrophy is 0.66% in all ages
• As per National Institute for Health and Care Excellence (NICE) 2019, the prevalence rate of Geographic Atrophy in the United Kingdom was found to be between 1.3%-6.7%
• Key Geographic Atrophy Companies: Apellis Pharmaceuticals, Iveric bio., Belite Bio, NGM Biopharmaceuticals, Novartis, CellCure Neurosciences, and others
• Key Geographic Atrophy Therapies: Pegcetacoplan, Zimura, LBS-008, NGM621, PPY988/GT005, OpRegen, and others
Geographic Atrophy Overview
Geographic Atrophy (GA) is an advanced form of age-related macular degeneration (AMD).Macular degeneration also called age-related macular degeneration (AMD or ARMD) is a medical condition that may result in blurred or no vision in the center of the visual field. There are two basic types of macular degeneration: "dry" and "wet". According to the "American Macular Degeneration Foundation," approximately 85-90%of the cases of macular degeneration are the "dry" (atrophic) type.
Get a Free sample for the Geographic Atrophy Market Report:
https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Geographic Atrophy Market
The dynamics of the Geographic Atrophy market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
Geographic Atrophy Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Geographic Atrophy Epidemiology Segmentation:
The Geographic Atrophy market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Geographic Atrophy
• Prevalent Cases of Geographic Atrophy by severity
• Gender-specific Prevalence of Geographic Atrophy
• Diagnosed Cases of Episodic and Chronic Geographic Atrophy
Download the report to understand which factors are driving Geographic Atrophy epidemiology trends @ Geographic Atrophy Epidemiological Insight
https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Geographic Atrophy Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Geographic Atrophy market or expected to get launched during the study period. The analysis covers Geographic Atrophy market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Geographic Atrophy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
To know more about Geographic Atrophy treatment, visit @ Geographic Atrophy Medications
https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Geographic Atrophy Therapies and Key Companies
• Pegcetacoplan: Apellis Pharmaceuticals
• Zimura: Iveric bio.
• LBS-008: Belite Bio
• NGM621: NGM Biopharmaceuticals
• PPY988/GT005: Novartis
• OpRegen: CellCure Neurosciences
Geographic Atrophy Market Drivers
• Increasing prevalence rate
• Geographic Atrophy Emerging novel treatment options
• Patient-friendly Dosage Regimes
Geographic Atrophy Market Barriers
• Failure of Investigational
• Limited knowledge of Geographic Atrophy
• Lack of access to specialists
Scope of the Geographic Atrophy Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Geographic Atrophy Companies: Apellis Pharmaceuticals, Iveric bio., Belite Bio, NGM Biopharmaceuticals, Novartis, CellCure Neurosciences, and others
• Key Geographic Atrophy Therapies: Pegcetacoplan, Zimura, LBS-008, NGM621, PPY988/GT005, OpRegen, and others
• Geographic Atrophy Therapeutic Assessment: Geographic Atrophy current marketed and Geographic Atrophy emerging therapies
• Geographic Atrophy Market Dynamics: Geographic Atrophy market drivers and Geographic Atrophy market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Geographic Atrophy Unmet Needs, KOL's views, Analyst's views, Geographic Atrophy Market Access and Reimbursement
Discover more about therapies set to grab major Geographic Atrophy market share @ Geographic Atrophy market forecast
https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Geographic Atrophy Market Report Introduction
2. Executive Summary for Geographic Atrophy
3. SWOT analysis of Geographic Atrophy
4. Geographic Atrophy Patient Share (%) Overview at a Glance
5. Geographic Atrophy Market Overview at a Glance
6. Geographic Atrophy Disease Background and Overview
7. Geographic Atrophy Epidemiology and Patient Population
8. Country-Specific Patient Population of Geographic Atrophy
9. Geographic Atrophy Current Treatment and Medical Practices
10. Geographic Atrophy Unmet Needs
11. Geographic Atrophy Emerging Therapies
12. Geographic Atrophy Market Outlook
13. Country-Wise Geographic Atrophy Market Analysis (2019-2032)
14. Geographic Atrophy Market Access and Reimbursement of Therapies
15. Geographic Atrophy Market Drivers
16. Geographic Atrophy Market Barriers
17. Geographic Atrophy Appendix
18. Geographic Atrophy Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Geographic Atrophy Pipeline https://www.delveinsight.com/report-store/geographic-atrophy-ga-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Geographic Atrophy Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Geographic Atrophy market. A detailed picture of the Geographic Atrophy pipeline landscape is provided, which includes the disease overview and Geographic Atrophy treatment guidelines.
Geographic Atrophy Epidemiology https://www.delveinsight.com/report-store/geographic-atrophy-ga-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Geographic Atrophy Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Geographic Atrophy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market
DelveInsight's "Crows Feet Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Crows Feet, historical and forecasted epidemiology as well as the Crows Feet market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Dermatitis Seborrheic Market https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market
DelveInsight's "Seborrhoeic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Seborrhoeic Dermatitis, historical and forecasted epidemiology as well as the Seborrhoeic Dermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Gastro Intestinal Bleeding Market https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market
DelveInsight's "Gastro Intestinal Bleeding Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastro Intestinal Bleeding, historical and forecasted epidemiology as well as the Gastro Intestinal Bleeding market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
DelveInsight's comprehensive report titled "Listeriosis Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Listeriosis. The report presents historical and projected epidemiological data covering incident cases of listeriosis, age-specific cases of listeriosis, gender-specific cases of listeriosis, risk-associated cases of listeriosis, and treated cases of listeriosis.
Point Of Care Glucose Testing Market https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market
DelveInsight's 'Point of Care Glucose Testing Market Insight, Competitive Landscape and Market Forecast, 2030' report delivers an in-depth understanding of Point of Care Glucose Testing and the historical and forecasted Point of Care Glucose Testing market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Substance Drug Abuse Market https://www.delveinsight.com/report-store/substance-drug-abuse-market
DelveInsight's "Substance (Drug) Abuse Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Substance (Drug) Abuse, historical and forecasted epidemiology as well as the Substance (Drug) Abuse market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Geographic Atrophy Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Apellis Pharmaceuticals, Iveric bio., Belite Bio, NGM Biopharmaceuticals, Novartis, CellCure Neurosciences here
News-ID: 3512182 • Views: …
More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…

Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…

Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…

Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Geographic
Geographic Information System (GIS) Software Global Market Report 2024 - Geograp …
"The Business Research Company recently released a comprehensive report on the Global Geographic Information System (GIS) Software Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The…
Cybersecurity Market Regional Analysis | Evaluating Geographic Trends
Cybersecurity Market Scope and Overview
In the digital era, where information is the new currency, cybersecurity emerges as a paramount concern for individuals, businesses, and governments alike. With the exponential growth of cyber threats, the global Cybersecurity Market has witnessed a surge in demand for innovative solutions and services to safeguard sensitive data and critical infrastructure. This report delves into a comprehensive analysis of the cybersecurity market, covering key players, market…
Geographic Information System - Comprehensive Analysis
GIS is used to power millions of decisions every day all over the world, such as examining crime patterns, pinpointing novel store locations, directing in-car navigation, and predicting and forecasting the weather, among others. The growing demand for location-based analytics among businesses to enhance operational efficiency and improve decision-making is driving the market growth. Similarly, the necessity to combine traditional data with three-dimensional data to get valuable insights from location-based…
Automobile Accessories Market: Charting New Geographic Territory
An extensive analysis of the Automobile Accessories market strategy of the leading companies in the precision of import/export consumption, supply and demand figures, cost, price, revenue and gross margins. The report starts by an introduction about the company profiling and a comprehensive review about the strategy concept and the tools that can be used to assess and analyze strategy. It also analyzes the company’s strategy in the light of Porter’s…
Geographic Atrophy - Pipeline Review, H2 2018 - ResearchByMarkets.com
"Geographic Atrophy - Pipeline Review, H2 2018", provides an overview of the Geographic Atrophy (Ophthalmology) pipeline landscape.
Geographic atrophy is an advanced form of age-related macular degeneration that can result in the progressive and irreversible loss of retina which can lead to a loss of visual function over time. Symptoms include difficulty during reading. Risk factors include smoking, thyroid hormones or antacids and in patients with coronary heart diseases and cataract…
MapsOfWorld.com partners with National Geographic Maps
MapsOfWorld.com has proudly partnered with National Geographic Maps to sell National Geographic maps and atlases in the United States. All wall maps are available at an initial discount of 15%, along with additional discounts on bulk items ordered by corporations and schools. Range of products available for sale include: paper and laminated wall maps, mural (wall paper) maps, travel maps and atlases. Wall maps are available in National Geographic’s three…